Mara Aspinall, Professor of Practice in CHS, is Partner at Illumina Ventures and editor of Senstive & Specific: The Testing Newsletter.

Michael researchers the socioethical implications of emerging technologies with an emphasis on national security. She has a particular interest on the technological trajectory of implantable technologies.

Industry pioneer mobile 3G/4G/5G and now 6G; award-winning fintech: investment banking, personal finance/advising, cognitive/behavioral finance; e-commerce; healthcare: insurance, AI-guided Dx/decision-support in finance & medicine, tele-medicine.

Dr. Keller is an academic colorectal surgeon, innovator and entrepreneur who serves as Program Chair of the IMPACT Biodesign Program, where she leads multidisciplinary education in need-based health technology innovation.